Overview

The Efficacy and Safety of Ta1 for Sepsis

Status:
Completed
Trial end date:
2021-03-23
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether thymalfasin is safe and effective in patients who have sepsis
Phase:
Phase 3
Details
Lead Sponsor:
Sun Yat-sen University
Collaborator:
SciClone Pharmaceuticals
Treatments:
Thymalfasin